Oncogenes in relation to immune responses
februar 16, 2024In our tenth episode of the “Immuno Oncology Talks”, we will discuss oncogenes in relation to immune responses with our…Cancer Immunotherapy and the role of Microbiome
juni 24, 2023In our ninth episode of the “Immuno Oncology Talks”, we will discuss the rapidly evolving field of the microbiome in…Cancer cell and gene therapies and the challenges to access the market
maj 28, 2023In this episode, we will hear about the current challenges of getting cancer cell and gene therapies on the market…Therapeutic RNA vaccines in cancer Immunotherapy
marts 29, 2023This episode, the seventh of our “Immuno Oncology Talks”, will be covering “Therapeutic RNA vaccines in cancer immunotherapy”, with our…Non-viral RNA treatment approaches in Cancer Immunotherapy
februar 22, 2023In our sixth episode of “Immuno Oncology Talks”, we will discuss non-viral RNA treatment approaches in cancer immunotherapyNon-viral RNA treatment approaches in Cancer Immunotherapy
februar 22, 2023In our sixth episode of “Immuno Oncology Talks”, we will discuss non-viral RNA treatment approaches in cancer immunotherapy with our…Adoptive therapy with engineered T cell receptors
januar 25, 2023In the current, and fifth episode of the “Immuno Oncology Talks”, we discuss adoptive therapy with engineered T cell receptors,…Targeting Neutrophils as effector cells in cancer therapy
december 13, 2022The fourth episode of “Immuno Oncology Talks” will shed light on neutrophils as effector cells in cancer therapyTargeting Neutrophils as effector cells in cancer therapy
december 12, 2022The fourth episode of “Immuno Oncology Talks”, Professor Marjolein van Egmond from the Amsterdam University Medical Center, in the Netherlands,…Tumor-Infiltrating Lymphocyte Based Adoptive Cellular Therapy
november 9, 2022In the third episode of the “Immuno Oncology Talks”, we have had the pleasure to discuss tumor infiltrating lymphocytes for…
